PROFESSIONAL EDITION

The largest community of pharma leaders

Admin

2806 articles

Rheos Medicines Appoints Barbara S. Fox as Chief Executive Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rheos Medicines, a biopharmaceutical company harnessing insights in immunometabolism to create a new class of therapeutics for patients with severe autoimmune disorders,...

ReViral Announces Appointment of Alan Musso as Chief Financial Officer

LONDON--(BUSINESS WIRE)--ReViral Ltd., a clinical-stage company focused on developing novel, antiviral compounds that target respiratory syncytial virus (RSV), today announced the appointment of Alan...

STALICLA Appoints Stéphane Baudouin as Chief of Science

GENEVA & BARCELONA, Spain--(BUSINESS WIRE)--STALICLA is delighted to announce the appointment of Stéphane Baudouin as Chief of Science effective from October 10, 2019. Stéphane...

Lysogene Appoints Mr. Stéphane Durant des Aulnois as Chief Financial Officer

PARIS--(BUSINESS WIRE)--Regulatory News: Lysogene (Paris:LYS) (FR0013233475 – LYS), a pioneering Phase 3 biopharmaceutical company specializing in gene therapy targeting central nervous system (CNS) diseases, today...

Enzyvant Appoints Jeb Ledell as Chief Operating Officer

CAMBRIDGE, Mass. & BASEL, Switzerland--(BUSINESS WIRE)--Enzyvant, a biopharmaceutical company focused on developing and commercializing transformative therapies for patients with rare, life-threatening conditions, today announced...

Announcement of New President and Chief Executive Officer for Ag-West Bio

SASKATOON, Saskatchewan--(BUSINESS WIRE)--The Board of Directors of Ag-West Bio Inc. is pleased to announce the appointment of Karen Churchill as the organization’s next president...